Science Explorer Back to mapMap
Discussion
Company · Wellesley · United States

Janus Biotherapeutics (United States)

Research works
2
▼ 22% vs 2018-21
Citations
55
27.0 per fractional work
Top-10% rate
20.0%
all institutions 10.0%
Open access
46%
world 40%
International
26%
world 18%
Janus Biotherapeutics (United States)

Not ranked overall: Janus Biotherapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Janus Biotherapeutics (United States) work in?

In all years, 60% of research at Janus Biotherapeutics (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (30%), Medicine (30%), Immunology and Microbiology (15%). It does 1.3× the world's share of Life Sciences.

Life Sciences60%Physical Sciences10%Health Sciences30%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology130.0%
    2. Immunology and Microbiology015.0%
    3. Neuroscience015.0%
    1. Medicine130.0%
    1. Engineering010.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Janus Biotherapeutics (United States)?

The most cited paper from Janus Biotherapeutics (United States) is "Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model" (Aman Preet Singh, Xirong Zheng, Xiefan Lin‐Schmidt et al., 2019), with 120 citations. Next come "Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives" (51) and "Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper" (18).

Most cited papers
#PaperReleasedCitations
1 Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model Aman Preet Singh, Xirong Zheng, Xiefan Lin‐Schmidt et al. · mAbs Open access 18 Dec 2019 120
2 Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives Jayaprakasam Bolleddula, Kevin Brady, Gerard J. M. Bruin et al. · Drug Metabolism and Disposition 12 Feb 2022 51
3 Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper Kathryn Ball, Gerard J. M. Bruin, Enrique Escandón et al. · Drug Metabolism and Disposition Open access 11 Feb 2022 18
4 PR1P, a VEGF-stabilizing peptide, reduces injury and inflammation in acute lung injury and ulcerative colitis animal models Avner Adini, Victoria H. Ko, Mark Puder et al. · Frontiers in Immunology Open access 28 Apr 2023 9
5 A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model Songmao Zheng, Jin Niu, Brian J. Geist et al. · mAbs Open access 2020 7
All 5 most cited papers, with filters and sorting

Which research topics does Janus Biotherapeutics (United States) publish most on?

By volume in 2022-now: Inflammation biomarkers and pathways, Inflammasome and immune disorders, Protein purification and stability and Immune Response and Inflammation.

  1. 1 Inflammation biomarkers and pathways Immunology 0 works
  2. 2 Inflammasome and immune disorders Molecular Biology 0 works
  3. 3 Protein purification and stability Molecular Biology 0 works
  4. 4 Immune Response and Inflammation Immunology 0 works
  5. 5 Transgenic Plants and Applications Biotechnology 0 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 0 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.4%not open53.6%

World: 40% of research is openly available.

with international co-authors26.3%domestic only73.7%

World: 18% is written across borders.

How has Janus Biotherapeutics (United States)'s research output changed?

Output in 2022-2025 was 22% lower than in 2018-2021.

200020102020

Other research institutions in Wellesley

All research institutions in Wellesley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Janus Biotherapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.